Clinical Trials Logo

Clinical Trial Summary

To assess the pattern of NGAL and Hepicidin in relation to anemia in End Stage Renal Disease Patients on regular hemodialysis in Assiut University Hospital and study the relation between both NGAL and Hepicidin.


Clinical Trial Description

Patients with chronic kidney disease have a chronic inflammatory state, due to many factors e.g. enhancedincidence of infections, the uremic milieu, elevated levels of proinflammatory cytokines, frequent presence of widespread arteriosclerosis, etc. Iron metabolism is disturbedin chronic inflammatory diseases.AlteredNGAL levels in hemodialysis patients was probablydue to the fact that this protein was involved in ironmetabolism and suggested that NGAL might be anew tool in the assessment of iron deficiency.Another study found in multipleregression analysis that; residual renal function, hepcidin,creatinine and hsCRP were predictors of serum NGAL inhemodialyzed patients. They concluded that NGAL is highly induced in dialyzed patients and could reflect both kidney function and iron metabolism.Several studies suggested that hepcidin plays a role as anegative regulator of intestinal iron absorption and ironrelease from macrophages. Hepcidin controls intestinal ironabsorption by regulating ferroportin expression on thebasolateral membrane of enterocytes .Hepicidin is also an acute phase reactant.Both NGAL and hepcidin are elevated inchronic kidney disease,not only through ironmetabolism, but both are also associated with inflammationand may be related to anemia. Possible relationship between NGAL and hepicidin is still under study. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04083664
Study type Observational
Source Assiut University
Contact Mohammed Hussein, Master
Phone +201005453884
Email drmohmedh@gmail.com
Status Not yet recruiting
Phase
Start date September 4, 2019
Completion date October 2020

See also
  Status Clinical Trial Phase
Not yet recruiting NCT04538443 - Impact of CKD on Children and Their Families
Recruiting NCT06416761 - Genetics in the Progression of Nephropathies
Recruiting NCT04381143 - ASPIrin in Reducing Events in Dialysis ( ASPIRED ) Phase 4
Recruiting NCT05858437 - Impact of Propionic Acid on Regulatory T Cell Function in Children With CKD N/A
Active, not recruiting NCT03350425 - Duration of Protection From Pneumonia After Pneumococcal Vaccination in Hemodialysis Patients